IMVT: IMMUNOVANT, INC. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 6 sales totaling $460K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-07 | Van Tuyl Christopher | Officer | $43K | |
| 2026-10-07 | Gloria Melanie | Officer | $72K | |
| 2026-10-07 | Stout Jay S | Officer | $71K | |
| 2026-10-07 | Stout Jay S | Officer | $51K | |
| 2026-10-02 | Venker Eric | CEO | $120K | |
| 2026-09-23 | Van Tuyl Christopher | Officer | $103K |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | Deep Track Capital, LP | 4.55% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.